This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sentinel Node With Ultrasound Contrast in Melanoma

This study has been completed.
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: August 29, 2006
Last updated: June 17, 2008
Last verified: June 2008

The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.

The goal is to improve the method for detecting sentinel node(s) in melanoma.

Condition Intervention
Malignant Melanoma Drug: ultrasound contrast

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Diagnostic
Official Title: Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma

Resource links provided by NLM:

Further study details as provided by Rigshospitalet, Denmark:

Estimated Enrollment: 20
Study Start Date: August 2006
Estimated Study Completion Date: April 2008
Estimated Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Malignant melanoma on a extremity,
  • No spread of the cancer,
  • Patients over 18 years old,

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Severe hart disease,
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00370136

Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Principal Investigator: Michael B Nielsen, MDSc Department of Radiology, section ultrasound
  More Information Identifier: NCT00370136     History of Changes
Other Study ID Numbers: (KF)01288200
Study First Received: August 29, 2006
Last Updated: June 17, 2008

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas processed this record on September 19, 2017